Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Clinical trial NCT00111475 · COMPLETED

Trial details

NCT number: NCT00111475
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2002-07-01
Primary completion: 2004-06-17
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.